146 related articles for article (PubMed ID: 32839916)
21. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
[TBL] [Abstract][Full Text] [Related]
22. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
Nelson RA; Lai LL
Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
[TBL] [Abstract][Full Text] [Related]
23. Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program.
Begg CB; Zhang ZF; Sun M; Herr HW; Schantz SP
Am J Epidemiol; 1995 Sep; 142(6):653-65. PubMed ID: 7653476
[TBL] [Abstract][Full Text] [Related]
24. Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers.
Adjei Boakye E; Wang M; Sharma A; Jenkins WD; Osazuwa-Peters N; Chen B; Lee M; Schootman M
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1765-1779. PubMed ID: 32356175
[TBL] [Abstract][Full Text] [Related]
25. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
[TBL] [Abstract][Full Text] [Related]
26. Temporal trends in the risk of second primary cancers among survivors of adult-onset cancers, 1980 through 2013: An Australian population-based study.
Ye Y; Otahal P; Wills KE; Neil AL; Venn AJ
Cancer; 2018 Apr; 124(8):1808-1818. PubMed ID: 29370456
[TBL] [Abstract][Full Text] [Related]
27. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.
Li J; Siegel DA; King JB
Ann Epidemiol; 2018 May; 28(5):328-330. PubMed ID: 29678312
[TBL] [Abstract][Full Text] [Related]
28. Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study.
Pandit AA; Halpern MT; Gressler LE; Kamel M; Payakachat N; Li C
Cancer Causes Control; 2024 Apr; 35(4):647-659. PubMed ID: 38001335
[TBL] [Abstract][Full Text] [Related]
29. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
[TBL] [Abstract][Full Text] [Related]
30. Second primary lung cancer in United States Cancer Survivors, 1992-2008.
Donin NM; Kwan L; Lenis AT; Drakaki A; Chamie K
Cancer Causes Control; 2019 May; 30(5):465-475. PubMed ID: 30900065
[TBL] [Abstract][Full Text] [Related]
31. Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.
Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
PLoS One; 2015; 10(10):e0140693. PubMed ID: 26469085
[TBL] [Abstract][Full Text] [Related]
32. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
Abhyankar N; Hoskins KF; Abern MR; Calip GS
BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
[TBL] [Abstract][Full Text] [Related]
33. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
Pawlish KS; Schottenfeld D; Severson R; Montie JE
Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
[TBL] [Abstract][Full Text] [Related]
34. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
35. Declining second primary ovarian cancer after first primary breast cancer.
Schonfeld SJ; Berrington de Gonzalez A; Visvanathan K; Pfeiffer RM; Anderson WF
J Clin Oncol; 2013 Feb; 31(6):738-43. PubMed ID: 23284037
[TBL] [Abstract][Full Text] [Related]
36. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
37. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
[TBL] [Abstract][Full Text] [Related]
38. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.
Berrington de Gonzalez A; Curtis RE; Kry SF; Gilbert E; Lamart S; Berg CD; Stovall M; Ron E
Lancet Oncol; 2011 Apr; 12(4):353-60. PubMed ID: 21454129
[TBL] [Abstract][Full Text] [Related]
39. Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000-2016.
Mukand NH; Zolekar A; Ko NY; Calip GS
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2220-2229. PubMed ID: 32856609
[TBL] [Abstract][Full Text] [Related]
40. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]